ILMN

Illumina Inc. Common Stock (ILMN)

Stock · NASDAQ · Health Care

$215.59as of 8/28/2026

AI Market Commentary

AI-generated

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

August 29, 2026

Illumina's recent earnings draw renewed analyst attention. A recent Seeking Alpha piece discusses Illumina's latest earnings and suggests that any dip in the share price could be a level to watch, framing the results in the context of the company's broader business. The article focuses on how the print was received and what it may signal about near-term sentiment toward the stock. As supporting context, shares have been moving with above-average volatility and are trading well below the average analyst price target, which sits meaningfully above the current level.

Active signals

High Beta26.6%
Support level
$187.28
Industry
Medical Specialities

About ILMN

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targe…

Sector
Health Care
Industry
Medical Specialities
Employees
8,600

Fundamentals

1-day range
$214.61$225.09
Market cap
$29.98B
P/E (trailing)
34.73
P/E (forward)
35.36
EPS (trailing)
$5.38
Dividend yield
Beta
1.46
Avg. volume
1.98M
52-week range
$88$231.81
Next earnings: October 29, 2026 · EPS estimate $1.36After Closeconfirmed

How Illumina Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$4.34BNet Income$850.00M (20%)Cost of Revenue$1.41B (32%)SG&A$1.09B (25%)R&D$967.00M (22%)Tax$236.00M (5%)ILMN

Source: 10-K filed Feb 12, 2026 · via SEC EDGAR / Finnhub

Forecasts

19 analyst ratings

Buy 61%
Hold 29%
Sell 11%
1-year price forecast
High
$230
+6.7%
Median
$211
-2.1%
Low
$113
-47.6%

Illumina Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • ILMN
    Illumina Inc. Common Stock
    $215.65
    ▼ 5.29%
    Market cap $29.98BP/E 34.73
    $88$231.81
  • CNC
    Centene Corporation Common Stock
    $64.77
    ▼ 0.86%
    Market cap $31.50BP/E
    $28.24$69.36
  • GH
    Guardant Health Inc. Common Stock
    $161.76
    ▼ 4.01%
    Market cap $21.31BP/E
    $53.4$176.58
  • NTRA
    Natera Inc. Common Stock
    $326.47
    ▼ 3.61%
    Market cap $38.72BP/E
    $157.43$343.18
  • MOH
    Molina Healthcare Inc Common Stock
    $199.88
    ▲ 0.57%
    Market cap $10.17BP/E 1249.59
    $121.06$244.89
  • OSCR
    Oscar Health Inc. Class A Common Stock
    $30.47
    ▲ 1.38%
    Market cap $9.27BP/E 16.85
    $10.69$33.55
  • BLLN
    BillionToOne Inc. Class A Common Stock
    $93.27
    ▼ 1.98%
    Market cap $6.32BP/E 117.67
    $61.96$150.44

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
9.8K
Disposed
733.9K

Institutional Ownership

March 31, 2026

Total shares held
147.77M
Total value held
$17.72B
Institutional holders
834
Top holders this quarter
  • Unknown19.02M
  • Unknown15.55M
  • Unknown6.59M
  • Unknown6.43M
  • Unknown5.92M
  • Unknown3.98M
  • Unknown3.83M
  • Unknown3.28M
  • Unknown3.05M
  • Unknown2.94M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.